Select Publications
Book Chapters
2023, 'Neuropathy and Other Neurological Problems in Chronic Kidney Disease', in Management of Chronic Kidney Disease, Springer International Publishing, pp. 417 - 427, http://dx.doi.org/10.1007/978-3-031-42045-0_28
,2014, 'Neuropathy and Other Neurological Problems in Chronic Kidney Disease', in Arici M (ed.), Management of Chronic Kidney Disease, Springer, pp. 343 - 352, http://dx.doi.org/10.1007/978-3-642-54637-2_26
,Journal articles
2022, 'Adolescent exposure to a solid high-fat, high-sugar ‘cafeteria’ diet leads to more pronounced changes in metabolic measures and gut microbiome composition than liquid sugar in female rats', Appetite, 172, http://dx.doi.org/10.1016/j.appet.2022.105973
,2022, 'Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders', Pharmaceuticals, 15, pp. 607, http://dx.doi.org/10.3390/ph15050607
,2022, 'Peripheral nerve morphology and intraneural blood flow in chronic kidney disease with and without diabetes', Muscle and Nerve, 65, pp. 603 - 607, http://dx.doi.org/10.1002/mus.27513
,2022, 'Peripheral neuropathy: An important contributor to physical limitation and morbidity in stages 3 and 4 chronic kidney disease', Nephrology Dialysis Transplantation, 37, pp. 713 - 719, http://dx.doi.org/10.1093/ndt/gfab043
,2022, 'Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions', Diabetes and Metabolism Journal, 46, pp. 198 - 221, http://dx.doi.org/10.4093/dmj.2021.0347
,2021, 'Effect of exenatide on peripheral nerve excitability in type 2 diabetes', Clinical Neurophysiology, 132, pp. 2532 - 2539, http://dx.doi.org/10.1016/j.clinph.2021.05.033
,2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120
,2021, 'Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes', European Journal of Neurology, 28, pp. 2074 - 2082, http://dx.doi.org/10.1111/ene.14805
,2020, 'Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes', Diabetic Medicine, 37, pp. 1553 - 1560, http://dx.doi.org/10.1111/dme.14306
,2020, 'Evidence of altered peripheral nerve function in a rodent model of diet-induced prediabetes', Biomedicines, 8, pp. 313, http://dx.doi.org/10.3390/biomedicines8090313
,2020, 'Altered peripheral nerve structure and function in latent autoimmune diabetes in adults', Diabetes/Metabolism Research and Reviews, 36, http://dx.doi.org/10.1002/dmrr.3260
,2019, 'Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients', Clinical Neurophysiology, 130, pp. 2088 - 2095, http://dx.doi.org/10.1016/j.clinph.2019.08.005
,2019, 'Polymer brush based fluorescent immunosensor for direct monitoring of interleukin-1β in rat blood', Analyst, 144, pp. 5682 - 5690, http://dx.doi.org/10.1039/c9an01300h
,2019, 'Potassium control in chronic kidney disease: implications for neuromuscular function', Internal Medicine Journal, 49, pp. 817 - 825, http://dx.doi.org/10.1111/imj.14114
,2018, 'The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study', Clinical Neurophysiology, 129, pp. 889 - 894, http://dx.doi.org/10.1016/j.clinph.2018.02.120
,2018, '<em>In Vivo </em>Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing', Journal of Visualized Experiments, http://dx.doi.org/10.3791/56102-v
,2018, 'In vivo electrophysiological measurement of the rat ulnar nerve with axonal excitability testing', Journal of Visualized Experiments, 2018, http://dx.doi.org/10.3791/56102
,2018, 'Effects of hemodialysis on intraneural blood flow in end-stage kidney disease', Muscle and Nerve, 57, pp. 287 - 293, http://dx.doi.org/10.1002/mus.25704
,2017, 'Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD', Clinical Journal of the American Society of Nephrology, 12, pp. 1569 - 1577, http://dx.doi.org/10.2215/CJN.00670117
,2017, 'The effect of diabetes on cortical function in stroke: Implications for poststroke plasticity', Diabetes, 66, pp. 1661 - 1670, http://dx.doi.org/10.2337/db16-0961
,2017, 'Haemodialysis alters peripheral nerve morphology in end-stage kidney disease', Clinical Neurophysiology, 128, pp. 281 - 286, http://dx.doi.org/10.1016/j.clinph.2016.09.010
,2017, 'Nerve excitability in the rat forelimb: a technique to improve translational utility', Journal of Neuroscience Methods, 275, pp. 19 - 24, http://dx.doi.org/10.1016/j.jneumeth.2016.10.013
,2016, 'Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes', Muscle and Nerve, 54, pp. 967 - 969, http://dx.doi.org/10.1002/mus.25274
,2016, 'Comparative study to evaluate the effects of peritoneal and hemodialysis on peripheral nerve function', Muscle and Nerve, 54, pp. 58 - 64, http://dx.doi.org/10.1002/mus.25016
,2016, 'In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes', Clinical Neurophysiology, 127, pp. 1700 - 1706, http://dx.doi.org/10.1016/j.clinph.2015.11.047
,2016, 'Neurological complications in chronic kidney disease', JRSM Cardiovascular Disease, 5, pp. 2048004016677687 - 2048004016677687, http://dx.doi.org/10.1177/2048004016677687
,2015, 'Ion channel modulation as a therapeutic approach in multiple sclerosis', Current Medicinal Chemistry, 22, pp. 4366 - 4378, http://dx.doi.org/10.2174/0929867322666151029104452
,2015, 'Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus', Diabetes/Metabolism Research and Reviews, 31, pp. 175 - 182, http://dx.doi.org/10.1002/dmrr.2583
,2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022
,2013, 'Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies', Clinical Neurophysiology, 124, pp. 2079 - 2090, http://dx.doi.org/10.1016/j.clinph.2013.04.012
,2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324
,2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360
,2013, 'Effects of Axonal Ion-Channel Dysfunction on Quality of Life in Type 2 Diabetes.', Diabetes Care, 36, pp. 1272 - 1277, http://dx.doi.org/10.2337/dc12-1310
,2013, 'Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease', PLoS ONE, 8, pp. Article number e59055, http://dx.doi.org/10.1371/journal.pone.0059055
,2012, '20. Effects of altered axonal biophysical properties on quality of life in diabetic peripheral neuropathy', Clinical Neurophysiology, 123, pp. e75 - e75, http://dx.doi.org/10.1016/j.clinph.2011.11.029
,2012, 'Progressive axonal dysfunction precedes development of neuropathy in type 2 Diabetes.', Diabetes, 61, pp. 1592 - 1598, http://dx.doi.org/10.2337/db11-1509
,2011, 'Valididty and reliability of the swaymeter device for measuring postural sway', BMC Geriatrics, 11, pp. 63, http://dx.doi.org/10.1186/1471-2318-11-63
,2010, 'DIFFERENTIAL EFFECTS OF HAEMODIAFILTRATION ON HIGH FLUX HAEMODIALYSIS ON NERVE FUNCTION IN VITRO', NEPHROLOGY, 15, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Papers
2016, 'An axonal membrane excitability gradient could contribute to the length-dependent susceptibility to neuropathy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, pp. 878 - 878, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431634203497&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Effects of neuropathy on physical function and quality of life in moderate severity chronic kidney disease', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e4 - e4, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.031
,2013, 'Insulin pump therapy in type 1 diabetes: Potential to be neuroprotective', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e1 - e2, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.024
,2012, 'Effects of calcineurin inhibitor treatment on peripheral nerve function in renal transplant recipients', in American Journal of Transplantation, Boston, United States of America, pp. 116 - 116, presented at American Transplant Congress, Boston, United States of America, 02 June 2012 - 06 June 2012, http://dx.doi.org/10.1111/j.1600-6143.2012.04112.x
,2012, 'Evidence for a causal relationship between nerve dysfunction and hyperkalaemia in end-stage kidney disease', in Nephrology Dialysis Transplantation, Paris, France, pp. ii70 - ii72, presented at 49th Congress of the European Renal Association/European Dialysis and Transplant Association, Paris, France, 25 May 2012 - 27 May 2012, http://dx.doi.org/10.1093/ndt/gfs211
,2012, 'EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN NERVE DYSFUNCTION AND HYPERKALAEMIA IN END-STAGE KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. 70 - 70, presented at 49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), FRANCE, Paris, 24 May 2012 - 27 May 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311494700155&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Effects of Calcineurin Inhibitor Treatment on Peripheral Nerve Function in Renal Transplant Recipients', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, pp. 116 - 116, presented at American Transplant Congress, MA, Boston, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000303235500304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Altered axonal excitability in asymptomatic type 1 diabetic patients', in Clinical Neurophysiology, Elsevier, Gold Coast, Queensland, pp. e73 - e73, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 02 October 2011 - 05 October 2011, http://dx.doi.org/10.1016/j.clinph.2011.11.023
,2011, 'Evidence for distinct patterns of axonal excitability between type 1 and type 2 diabetic nerves', in Journal of the Peripheral Nervous System, Wiley, Potomac, Unites States of America, pp. S5 - S5, presented at Peripheral Nerve Society Meeting, Potomac, Unites States of America, 25 September 2011 - 29 September 2011, http://dx.doi.org/10.1111/j.1529-8027.2011.00335.x
,2011, 'Pre-diabetic neuropathy: Axonal dysfunction evident prior to clinical neuropathy', in Journal of the Peripheral Nervous System, Wiley, Potomac, Unites States of America, presented at Peripheral Nerve Society Meeting, Potomac, Unites States of America, 25 September 2011 - 29 September 2011, http://dx.doi.org/10.1111/j.1529-8027.2011.00335.x
,